Blood-Based MRD Testing Identifies AML Patients at Risk of Relapse After Stem Cell Transplant
Researchers looked at AML variants in the blood of patients prior to their allogeneic hematopoietic cell transplant and correlated them with subsequent relapse or death.
Heart Transplant Cell-Free DNA Test Enables Earlier Detection of Acute Rejection Than Biopsy
The researchers hope that donor-derived cell-free DNA testing to monitor rejection can help relieve racial disparities in heart transplant outcomes.
Liquid Biopsy Dx Looks for Donor-Derived DNA as Measure of Chronic Lung Transplant Rejection
A team led by researchers at the NHLBI are testing the efficacy of measuring ddcfDNA in blood as a biomarker of chronic rejection for lung transplants.